Results 101 to 110 of about 7,348 (201)

Failure of mesalamine to resolve the diarrhea of microscopic colitis suggests a comorbid illness [PDF]

, 2003
Charles Randall, Carlo Taboada, Jennifer Kimble   +2 more
openalex   +1 more source

Design and biological evaluation of mesalamine-NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapy. [PDF]

Sci Rep
Yahya M, Safaei-Ghomi J, Haghir-Ebrahimabadi A, Jalali H, Mojtabazadeh H.   +4 more
europepmc   +1 more source

DESIGN AND EVALUATION OF COLON SPECIFIC DRUG DELIVERY SYSTEM OF MESALAMINE

Krishnaveni. B, Srinivas. N, Vivek Sagar. P, Mamatha. T, Chandra Shekhar Reddy. B*   +4 more
openalex   +1 more source

TC22, a Novel Colorectal Cancer Biomarker Remains Continuously Suppressed Upon Repeated Mesalamine Exposure to Colorectal Cancer Cells

, 2011
Manisha Bajpai, Koushik K. Das, Kiron M. Das   +2 more
openalex   +1 more source

Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cells

, 2013
Vineeta Khare, Michaela Lang, Kyle Dammann, Christoph Campregher, Alex Lyakhovich, Christoph Gasché   +5 more
openalex   +1 more source

Randomized, Double-Blind, Double-Dummy, Multicenter Trial of a Herbal Preparation of Myrrh, Camomile and Coffee Coal Compared to Mesalamine in Maintaining Remission in Ulcerative Colitis

, 2011
Jost Langhorst, Ines Varnhagen, Berthold Schneider, Karl-Heinz Goos, Uwe Albrecht, Andreas Rueffer, Rainer Stange, Andreas Michalsen, Gustav Dobos   +8 more
openalex   +1 more source

Impact of Oral Mesalamine on Clinical Remission and Mucosal Response in Mild to Moderate Ulcerative Colitis: A Prospective Observational Study. [PDF]

Cureus
Nabeel L, Khurshid M, Amjad A, Abbas Raja A, Ishtiaq H, Hussain S, Umer MR, Jan HA, Khattak MI, Masood S.   +9 more
europepmc   +1 more source

Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey". [PDF]

Intest Res
Limsrivilai J, Leung WK.
europepmc   +1 more source

Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome - a study protocol. [PDF]

BMJ Open
Backman AS, Frank A, Lindberg LJ, Ljungman D, Silander G, Gustafsson RJ, Bozsó T, Schmidt PT, Ingre M, Mittlbock M, Löwbeer C, Marsal J, Lindblom A, Tham E, Therkildsen C, Gasche C, International MesaCAPP Study Group.   +16 more
europepmc   +1 more source

Natural History of Pediatric Patients With Crohn's Disease Treated With Mesalamine Therapy

, 2023
Denise Young, Sharon Perry, Sindhoosha Malay, Thomas J. Sferra, Michael Finkler, Jonathan Moses   +5 more
openalex   +1 more source